Additionally, FDA is proposing two other constraints around the submission of a supplemental PMTA. Below proposed § 1114.fifteen(a), a supplemental PMTA could not be submitted the place the marketing purchase for the original tobacco solution is withdrawn or continues to be briefly suspended or is t